MICHAEL N. MCCARTY LAW OFFICE PLLC for AMERICAN MEDICAL TECHNOLOGISTS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislation affecting payment for clinical laboratory diagnostic tests, including but not limited to COVID-19 tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Medical/Disease Research/Clinical Labs MED
Support S. 236, the Tracking COVID-19 Variants Act; support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; monitor legislative efforts to regulated laboratory-developed tests (LDTs); support initiatives to improve COVID-19 testing supply chains.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.